MARKET

OVID

OVID

Ovid Therapeutics Inc
NASDAQ
1.600
+0.150
+10.34%
After Hours: 1.570 -0.03 -1.88% 19:59 02/06 EST
OPEN
1.450
PREV CLOSE
1.450
HIGH
1.610
LOW
1.450
VOLUME
1.58M
TURNOVER
--
52 WEEK HIGH
2.010
52 WEEK LOW
0.2425
MARKET CAP
208.29M
P/E (TTM)
-3.1293
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at OVID last week (0126-0130)?
Weekly Report · 5d ago
Ovid Therapeutics: Bullish Post-PIPE With 2 Differentiated CNS Moonshots
Seeking Alpha · 01/27 04:01
Weekly Report: what happened at OVID last week (0119-0123)?
Weekly Report · 01/26 09:23
Weekly Report: what happened at OVID last week (0112-0116)?
Weekly Report · 01/19 09:25
Ovid Therapeutics Unveils Pipeline Advances Targeting Drug-Resistant Epilepsy and Neuropsychiatric Disorders
Reuters · 01/13 00:14
Weekly Report: what happened at OVID last week (0105-0109)?
Weekly Report · 01/12 09:25
Weekly Report: what happened at OVID last week (1229-0102)?
Weekly Report · 01/05 09:23
Weekly Report: what happened at OVID last week (1222-1226)?
Weekly Report · 12/29/2025 09:23
More
About OVID
Ovid Therapeutics Inc. is a biopharmaceutical company dedicated to developing small-molecule medicines for brain conditions with significant unmet need. It is advancing a pipeline of novel, targeted small-molecule candidates that modulate the intrinsic and extrinsic factors involved in neuronal hyperexcitability causative of multiple neurological and neuropsychiatric disorders. It develops OV329, which is a GABA-aminotransferase inhibitor, as a potential therapy for treatment-resistant seizures and other undisclosed indications; OV350, OV4071 and others within a library of compounds that directly activate the KCC2 transporter, for multiple CNS disorders. It also maintains the KCC2 library, which is a portfolio of potential first-in-class direct activators of potassium chloride cotransporter2. Both OV350 and OV4071 are intended for the potential treatment of psychosis associated with neuronal-synuclein diseases (NSD), which include Parkinson’s disease and Lewy body dementia (LBD).

Webull offers Ovid Therapeutics Inc stock information, including NASDAQ: OVID real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OVID stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading OVID stock methods without spending real money on the virtual paper trading platform.